Skip to main content

Day: September 24, 2025

Terra Clean Energy Corp. Enters into Definitive Agreements to Acquire Uranium Claims on The San Rafael Swell, Utah, United States

Vancouver B.C., Sept. 24, 2025 (GLOBE NEWSWIRE) —  TERRA CLEAN ENERGY CORP. (“Terra” or the “Company”) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0), is pleased to announce that, further to its press release dated September 16, 2025, it has entered into definitive agreements with arm’s length parties to acquire up to a 100% interest in each of the Wheel Anne Claims and the Green Vein Mesa Claims (each of the properties are located in Emery County, Utah, United States). “The quick execution of the agreements shows the Company’s commitment and excitement to these assets and to our already significant portfolio of low-risk uranium assets in world renowned uranium basins” state Greg Cameron, CEO of Terra. “Our plan is to have our team on the ground in Utah in the coming weeks working closely with our local partner.” To earn its respective...

Continue reading

OneMedNet Expands Into $1.5B Healthcare Data Annotation Market With MedCase

MINNEAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced a strategic partnership with Medcase, a worldwide network of healthcare professionals focused on medical data annotation. This collaboration establishes a new market entry point for OneMedNet and opens a high-growth revenue channel in the healthcare AI ecosystem. Strategic Expansion into Healthcare Data Annotation The global healthcare data annotation market, valued at $1.5 billion in 2025 and projected to be $2.8 billion by 2030, has entered a pivotal growth phase1. Scale AI’s $14.8B investment from Meta has disrupted the industry, triggering an exodus of major clients concerned about competitive intelligence. This shift has created an immediate...

Continue reading

Akari Therapeutics’ Preclinical Data Demonstrates the Potential of its Novel ADC Spliceosome Modulating Payload, PH1

Data highlights ability of Akari’s ADC payload, PH1, to suppress the levels of the AR-V7 receptor that is responsible for driving hormone refractory prostate cancer progression No current therapies have proven to be effective in AR-V7 driven tumors BOSTON and LONDON, Sept. 24, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced key preclinical data demonstrating the potential of its novel antibody drug conjugate (ADC) spliceosome modulating payload, PH1, for the treatment of tumors fueled by alternative splicing-drivers, such as the Androgen Receptor splice variant 7 (AR-V7) in prostate cancer. AR-V7 is a key driver for progression of metastatic castration resistant prostate cancer (mCRPC). During progression...

Continue reading

Ultrack Systems Inc. (OTC: MJLB) Subsidiary Better Pets Secures Canadian Trademark Registration and Advances U.S. Trademark Application

TORONTO, Sept. 24, 2025 (GLOBE NEWSWIRE) — Ultrack Systems Inc. (OTC: MJLB) (“Ultrack” or the “Company”), through its wholly owned subsidiary Better Pets (Better Health Sciences for Pets Corp.), is pleased to announce that it has officially secured a Canadian federal trademark registration for its “Better Pets” brand, while simultaneously advancing its pending U.S. trademark application with the United States Patent and Trademark Office (USPTO). The Canadian trademark (Registration No. TMA1339765, effective August 15, 2025) grants Better Pets the exclusive right to use the ® symbol across Canada for the next ten years, renewable in 2035. This legal protection safeguards the Company’s brand across physical retail, e-commerce, and social platforms while providing a strong foundation for domestic and international expansion. “This...

Continue reading

PRS REIT Plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: AXA Investment Managers S.A.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree PRS REIT plc, The(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an...

Continue reading

Birchtech Secures License Agreement with Large Regional Power Utility Company

New License Agreement Resolves Case Against Coal-Fired Utility, Dismisses Defendant from Litigation CORSICANA, Texas, Sept. 24, 2025 (GLOBE NEWSWIRE) — Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) (“Birchtech” or the “Company”), a leader in specialty activated carbon technologies for sustainable air and water treatment, today announced a non-exclusive agreement with a large regional coal-fired power utility that the Company filed suit against in January 2025 regarding the Company’s patented mercury emissions reduction technologies. The suit against this utility had been consolidated with the other cases that were originally filed in 2024 for pre-trial matters in Iowa. The license agreement with the regional utility includes a one-time license fee. Due to confidentiality agreements and ongoing litigation, other specific terms of the...

Continue reading

Sean Roosen and John Burzynski Join Falco as Special Advisors

MONTRÉAL, Sept. 24, 2025 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX.V: FPC) (“Falco” or the “Corporation”) is pleased to announce the appointment of Mr. Sean Roosen and Mr. John Burzynski as Special Advisors to Falco’s Management and Board of Directors (the “Board”) in respect of marketing, financing and project development strategies. Since 2014, both have been closely involved with Falco’s flagship Horne 5 Project, located in Rouyn-Noranda, Québec (the “Horne 5 Project” or the “Project”) through their various roles within the Osisko group of companies. They also bring a long-standing working relationship of more than a decade with Mr. Luc Lessard, President and CEO of Falco. Under their leadership, the Osisko group of companies successfully raised over $5.0 billion in capital to advance mining assets across the development...

Continue reading

AtlasClear Holdings Secures Additional $2,000,000 Led by 2 Board Members, Completing Previously Announced $5 Million in Funding

Signaling Leadership Confidence and Commitment to Company Forthcoming 10-K Filing and Earnings Call Scheduled for September 29–30, 2025, respectivelyTAMPA, Fla., Sept. 24, 2025 (GLOBE NEWSWIRE) — AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear Holdings” or the “Company”) today announced the successful closing of the remaining $2,000,000 of the previously announced $5 million company financing. AtlasClear Holdings, reported today that it has raised a total of $5 million in gross proceeds through the issuance of promissory notes from strategic investors and Board members, including the $3 million announced on September 17, 2025. The notes were issued with a 20% Original Issue Discount, such that they have an aggregate principal amount of $6,250,000 and mature on the earlier of six months or the date the Company completes...

Continue reading

Aeries Technology Announces Major Enterprise Client Expansion, Projected to Reach $12M+ Annualized Run-Rate by Fiscal Year-End

Expanded, multi-function engagement validates the September 4 expansion plan and strengthens recurring growth NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (NASDAQ: AERT), a global leader in AI-powered business transformation and Global Capability Center (GCC) services, today announced the expansion of an engagement with a recently signed global enterprise client. The expanded scope is expected to drive the client relationship to an annualized revenue run-rate exceeding $12 million by Aeries’ fiscal year-end, i.e. end of March 2026, with additional growth anticipated in subsequent quarters. The client is broadening its utilization of Aeries’ delivery platform across multiple functions—including artificial intelligence, technology services, finance, and customer support—leveraging Aeries’ delivery hubs in India...

Continue reading

Sono and Mitsubishi Heavy Industries Thermal Transport Europe strengthen partnership with integrated solar solution for electric reefer trailers

Subsidiary Sono Solar and MTTE unveil a fully integrated solar-powered system for eTRUs on semi-trailers; first demo trailer available for fleet trials and public showcase at NUFAM Karlsruhe, September 25–28, 2025 Munich, Sept. 24, 2025 (GLOBE NEWSWIRE) — Sono Group N.V. (Nasdaq: SSM) (hereafter referred to as “Sono” or the “Company”, parent company to Sono Motors GmbH, hereafter referred to as “SonoSolar” or “Subsidiary”), the solar technology company, today announced a new milestone in its commercial rollout: subsidiary Sono Solar and long-standing customer MTTE (Mitsubishi Heavy Industries – Thermal Transport Europe) are presenting one of the first fully integrated solar solutions for electric and hybrid trailer refrigeration units (eTRUs) in the European market. The integration pairs MTTE’s TEF1500 eTRU and battery pack with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.